US Stock Market Move | Parabilis Medicines (PBLS.US) debuts on the US stock market with the stock price surging over 44% after opening.
As of the deadline for submission, the stock has increased by 44.35%, to $28.87.
On Wednesday, the American biotechnology company Parabilis Medicines (PBLS.US) focused on cancer treatment, debuted on the US stock market. The stock price rose at the opening and, as of the time of writing, the stock was up 44.35% to $28.87. The IPO price was $20. Parabilis was founded in 2015 and is dedicated to developing treatment options for various cancers and rare tumors. The company plans to use the funds raised in the IPO to advance its leading candidate drug, zolucatetide, into later-stage clinical trials.
As of the end of the 2025 fiscal year, Parabilis had a net loss of $145.9 million and cash and cash equivalents of $27.7 million; the previous fiscal year had a net loss of $117.9 million and cash of $47.3 million.
Related Articles
US Stock Market Move | American distributed power system supplier ERock (EROC.US) debuted on the US stock market. The stock price fell over 7.5% after the opening.
JP Morgan expects the Federal Reserve to leave interest rates unchanged unanimously next week. May may be the peak of this round of inflation cycles.
US Stock Market Move | Coca-Cola Company (KO.US) rises by 3%, its stock price defies the trend and hits a new all-time high.
US Stock Market Move | American distributed power system supplier ERock (EROC.US) debuted on the US stock market. The stock price fell over 7.5% after the opening.
JP Morgan expects the Federal Reserve to leave interest rates unchanged unanimously next week. May may be the peak of this round of inflation cycles.
US Stock Market Move | Coca-Cola Company (KO.US) rises by 3%, its stock price defies the trend and hits a new all-time high.
RECOMMEND
